News

By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.

The genome editing tool CRISPR-Cas9 can eliminate HIV viruses from lab-cultured cells, according to not-yet peer-reviewed research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

Researchers have identified a mechanism that causes neurological problems in mice infected with the virus behind COVID-19, and also found a treatment that helped prevent these changes.

A vaccine against the bacterium that causes melioidosis was found to be highly protective against the highly fatal disease in animal studies.

The world's first gene-edited pig kidney transplant has been successful, reports Massachusetts General Hospital. The procedure marks a major milestone in the quest to provide more readily available organs to patients.

A new quick and precise technique for producing artificial human chromosomes has been developed, which could be used to power advanced gene therapies.

An investigational gene therapy for a rare neurodegenerative disease that begins in early childhood, known as giant axonal neuropathy, was well tolerated and showed signs of therapeutic benefit in a clinical trial.

Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell therapy from working.

Researchers have developed a process to bioengineer heparin, the world’s most widely used blood thinner, which is currently derived from pig intestines.

Human sweat contains a protein that may protect against Lyme disease, according to a study. About one-third of the population carries a genetic variant of this protein that is associated with Lyme disease in genome-wide association studies.